TITLE

Legal Pains from Super Painkiller

PUB. DATE
May 2004
SOURCE
Perspective (08889732);May2004, Vol. 19 Issue 5, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that the federal appeals court has upheld the dismissal of a lawsuit brought by the University of Rochester (UR), New York. Effort of the school to stop a major pharmaceutical company from using a UR patent to make the painkiller drug Celebrex; Claims of the UR; Injunction to halt Celebrex sales.
ACCESSION #
13286509

 

Related Articles

  • IN RE CARDIZEM & VALLEY DRUG CO.: THE HATCH-WAXMAN ACT, ANTICOMPETITIVE ACTIONS, AND REGULATORY REFORM. Burford, Larissa // Berkeley Technology Law Journal;Annual Review 2004, Vol. 19 Issue 1, p365 

    Reports that the Sixth Circuit and the Eleventh Circuit in the U.S. have reached conflicting resolutions on similar cases involving pharmaceutical patent settlements and alleged pharmaceutical antitrust violations. Means for combating potential antitrust violations stemming from Hatch-Waxman...

  • `An enemy of indigenous peoples.' Knight, Danielle // Multinational Monitor;Jun98, Vol. 19 Issue 6, p24 

    Reports on the plans of indigenous groups to challenge the patent claims of a pharmaceutical corporation in the United States on an Amazonian plant, Ayahuasca. Information on the conflict; Policy resolution adopted by the Coordinating Body for Indigenous Organizations in the Amazon (COICA);...

  • Going to Court. Singer, Jonathan // Pharmaceutical Executive;Oct2006, Vol. 26 Issue 10, p38 

    The article focuses on the patent lawsuits faced by pharmaceutical companies in the U.S. It points out that most cases that reached a judgment or verdict from 2002 to 2006 were heard in three of the most popular venues for generic litigation, the Northern District of Illinois, the Southern...

  • The Patent wars & changing scenario. VAIDYA, MANSI // BioSpectrum;Dec2012, Vol. 10 Issue 12, p20 

    The article analyzes the impact of pharmaceutical patent wars on the Indian healthcare system. It is said that several patent-related landmark decisions in the last few months in the country had far reaching consequences not only on international players but also on the domestic entities in the...

  • Whose Bright Idea…? Hitchcock, Julian // European Pharmaceutical Executive;Jul/Aug2005, p46 

    The article presents several cases related to patents in the pharmaceutical industry in Europe. One of those cases cited was that of Sabat SpA versus MFI case, which concerned burners on gas cookers, where the Court of Appeals uses law of collocation as a reference. Another was that the case of...

  • STUDENT REPORTING: CALIFORNIA SUPREME COURT TO RULE ON THE LEGALITY OF REVERSE PAYMENT SETTLEMENTS IN THE PHARMACACEUTICAL INDUSTRY. DeRoo, Christian // Health Law & Policy;Spring2012, Vol. 6 Issue 1, p43 

    The article discusses issues related to drugs patents in the U.S. It is stated that pharmaceutical companies that produce brand-name drugs settled patent litigation to potential rivals by making large payments in exchange of ending suits. It is informed that these "pay-for-delay" settlements...

  • Folkman countersuit attacks fraudulent" Abbott. Novak, Kristine // Nature Medicine;Sep2000, Vol. 6 Issue 9, p948 

    Reports that the Children's Hospital of Boston has countersued Abbott Laboratories Inc. for defamation and conspiracy, accusing the Illinois pharmaceutical giant of implementing a fraudulent scheme to obtain the patent rights to anti-angiogenic agents studied in the laboratory of Judah Folkman. ...

  • Court ruling could scupper patent deal. O'Driscoll, Cath // ICIS Chemical Business;5/15/2006, Vol. 1 Issue 19, p33 

    The article reports on a ruling by the European Court of Justice that could make it harder for pharmaceutical companies to obtain patent extensions for certain products in future. The Massachusetts Institute of Technology's application for a so-called supplementary protection certificate (SPC)...

  • MADEY V. DUKE UNIVERSITY: SHATTERING THE MYTH OF UNIVERSITIES' EXPERIMENTAL USE DEFENSE. Cai, Michelle // Berkeley Technology Law Journal;Annual Review 2004, Vol. 19 Issue 1, p175 

    Reports the the Federal Circuit has rejected an experimental use defense to a patent infringement lawsuit against a university in the "Madey v. Duke University" case in Durham, North Carolina. Elimination of the experimental use defense in academic research; Examination of the impact of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics